Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia. - Tamellini E; Sorio M; Andreini A; Tecchio C; Nadali G; Bernardelli A; Ferrarini I; Crosera L; Vatteroni A; Simio C; Benedetti F; Krampera M; et al. (Blood cell therapy, 2024)